We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene Variant Plus Stress Increase Depression Risk

By Biotechdaily staff writers
Posted on 25 Jul 2003
A study has found that among people who experience stressful events over five years, 43% of those with a short version of the serotonin transporter gene develop depression, compared to only 17% of those with a long version of the gene. More...
The findings were reported in the July 18, 2003, issue of Science.

Researchers followed 847 Caucasian New Zealanders, born in the early 1970s, from birth into adulthood. They found that 17% carried two copies of the stress-sensitive short version, 31% carried two copies of the protective long version, and 51% carried one copy of each version. After charting stressful life events from ages 21-26, such as homelessness, disabling injuries, debt, relationship problems, and abuse, they found that 17% of participants had a diagnosis of a major depression in the past year, and 3% had either attempted or thought about suicide. Carriers of the short version represented only 10% of the participants. Such events failed to predict a diagnosis of depression among those with two copies of the long variant.

Since the most widely prescribed class of antidepressants act by blocking the serotonin transporter gene, it has been a prime suspect in mood and anxiety disorders. However, eight previous studies did not detect its link to depression.

"We found the connection only because we looked at the study members' stress history,” noted Dr. Terrie Moffitt, of King's College London (UK), who conducted the research along with colleagues from King's College and the University of Wisconsin (Madison, USA).





Related Links:
King's College London
U. of Wisconsin

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Automatic CLIA Analyzer
Shine i6000
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.